Inflammation and Progression of CKD: The CRIC Study
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background and objectives: CKD is a global public health problem with significant mortality and morbidity. Design, setting, participants, & measurements: We examined the multivariable association of plasma levels of IL-1, IL-1 receptor antagonist, IL-6, TNF- α , TGF- β , high–sensitivity C–reactive protein, fibrinogen, and serum albumin with progression of CKD in 3430 Chronic Renal Insufficiency Cohort study participants. Results: Over a median follow-up time of 6.3 years, 899 participants reached the composite end point of ≥50% decline in eGFR from baseline or onset of ESRD. Elevated plasma levels of fibrinogen, IL-6, and TNF- α and lower serum albumin were associated with a greater decline in eGFR over time. After adjusting for demographics, BP, laboratory variables, medication use, and baseline eGFR, hazard ratios for the composite outcome were greater for the patients in the highest quartile of fibrinogen (hazard ratio, 2.05; 95% confidence interval, 1.64 to 2.55; P <0.001), IL-6 (hazard ratio, 1.44; 95% confidence interval, 1.17 to 1.77; P <0.01), and TNF- α (hazard ratio, 1.94; 95% confidence interval, 1.52 to 2.47; P <0.001) compared with those in the respective lowest quartiles. The hazard ratio was 3.48 (95% confidence interval, 2.88 to 4.21; P <0.001) for patients in the lowest serum albumin quartile relative to those in the highest quartile. When also adjusted for albuminuria, the associations of fibrinogen (hazard ratio, 1.49; 95% confidence interval, 1.20 to 1.86; P< 0.001), serum albumin (hazard ratio, 1.52; 95% confidence interval, 1.24 to 1.87; P <0.001), and TNF- α (hazard ratio, 1.42; 95% confidence interval, 1.11 to 1.81; P <0.001) with outcome were attenuated but remained significant. Conclusions: Elevated plasma levels of fibrinogen and TNF- α and decreased serum albumin are associated with rapid loss of kidney function in patients with CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CVDs in old age often develop in the context of multimorbidity and frailty”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [142]
In the citing paper
“inflammation also contributes to the pathogenesis of other chronic non-CVDs — such as anaemia, cancer, type 2 diabetes, dementia, osteoporosis, sarcopenia, chronic kidney disease, and depression”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [142]
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Self-citationLevey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Self-citationA Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Logistic Regression Using SAS: Theory and Application
Allison, P. D. (1999) · Cited by 2,991
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,479
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 974
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Gansevoort, R. T., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.531 · Cited by 883
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310345 · Cited by 784
Self-citationIntensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Self-citationProjecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010112 · Cited by 719
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215606 · Cited by 707
Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
Gupta, J., Mitra, N., Kanetsky, P. A., Devaney, J., Wing, M. R., Reilly, M., Shah, V. O., Balakrishnan, V. S., Guzman, N. J., Girndt, M., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03500412 · Cited by 603
Self-citationToss, H., Lindahl, B., Siegbahn, A., Wallentin, L., & Group, F. T. F. S. (1997) · Circulation · doi:10.1161/01.cir.96.12.4204 · Cited by 520
Involvement of IL-6 in mesangial proliferative glomerulonephritis.
Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.3949 · Cited by 408
Biomarkers of inflammation and progression of chronickidney disease
Tonelli, M., Sacks, F., Pfeffer, M., Jhangri, G. S., & Curhan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00398.x · Cited by 362
Macrophages in Kidney Injury, Inflammation, and Fibrosis
Cao, Q., Harris, D. C. H., & Wang, Y. (2015) · Physiology · doi:10.1152/physiol.00046.2014 · Cited by 341
Tarver-Carr, M. E., Powe, N. R., Eberhardt, M. S., LaVeist, T. A., Kington, R. S., Coresh, J., & Brancati, F. L. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026493.18542.6a · Cited by 284
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269
Nakamura, T., Miller, D., Ruoslahti, E., & Border, W. A. (1992) · Kidney International · doi:10.1038/ki.1992.183 · Cited by 247
Bleyer, A. J., Shemanski, L. R., Burke, G. L., Hansen, K. J., & Appel, R. G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00056.x · Cited by 239
Shankar, A., Sun, L., Klein, B. E. K., Lee, K. E., Muntner, P., Nieto Javier, F., Tsai, M. Y., Cruickshanks, K. J., Schubert, C. R., Brazy, P. C., et al. (2011) · Kidney International · doi:10.1038/ki.2011.283 · Cited by 231
(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227
Inflammatory and Prothrombotic Markers and the Progression of Renal Disease in Elderly Individuals
Fried, L., Solomon, C., Shlipak, M., Seliger, S., Stehman-Breen, C., Bleyer, A. J., Chaves, P., Furberg, C., Kuller, L., & Newman, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000146422.45434.35 · Cited by 227
Self-citationExpanding Priorities — Confronting Chronic Disease in Countries with Low Income
Anderson, G. F., & Chu, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068182 · Cited by 197
Progression of Chronic Renal Failure
Yu, H. T. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1417 · Cited by 179
Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
Upadhyay, A., Larson, M. G., Guo, C.-Y., Vasan, R. S., Lipinska, I., O’Donnell, C. J., Kathiresan, S., Meigs, J. B., Keaney, J. F., Rong, J., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq471 · Cited by 172
Snaedal, S., Heimbürger, O., Qureshi, A. R., Danielsson, A., Wíkström, B., Fellström, B., Fehrman‐Ekholm, I., Carrero, J. J., Alvestrand, A., Stenvinkel, P., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.02.008 · Cited by 138
Interleukin-6: An autocrine regulator of mesangial cell growth
COLEMAN, D. L., & Ruef, C. (1992) · Kidney International · doi:10.1038/ki.1992.91 · Cited by 137
Association Between Clinical Risk Factors and Progression of Chronic Kidney Disease in Children
Staples, A. O., Greenbaum, L. A., Smith, J. M., Gipson, D. S., Filler, G., Warady, B. A., Martz, K. L., & Wong, C. S. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07851109 · Cited by 136
Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis
Sörensen, I., Susnik, N., Inhester, T., Degen, J. L., Melk, A., Haller, H., & Schmitt, R. (2011) · Kidney International · doi:10.1038/ki.2011.214 · Cited by 116
Hiramoto, J. S., Katz, R., Peralta, C. A., Ix, J. H., Fried, L. F., Cushman, M., Siscovick, D. S., Palmas, W., Sarnak, M. J., & Shlipak, M. G. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.335 · Cited by 103
Self-citationTGF-β impairs renal autoregulation via generation of ROS
Sharma, K., Cook, A. K., Smith, M. P. W., Valancius, C., & Inscho, E. W. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00345.2004 · Cited by 103
Cytokine gene polymorphism and progression of renal and cardiovascular diseases
Rao, M., Wong, C. S., Kanetsky, P. A., Girndt, M., Stenvinkel, P., Reilly, M. P., & Raj, D. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002391 · Cited by 97
Self-citationFibrinogen, mortality and incident cardiovascular complications in end‐stage renal failure
Zoccali, C., Mallamaci, F., Tripepi, G. L., Cutrupi, S., Parlongo, S., Malatino, L., Bonanno, G., Rapisarda, F., Fatuzzo, P. M., Seminara, G., et al. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01180.x · Cited by 83
Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis
Raj, D. S., Moseley, P. L., Dominic, E. A., Onime, A., Tzamaloukas, A. H., Boyd, A., Shah, V. O., Glew, R. H., Wolfe, R. R., & Ferrando, A. A. (2008) · Kidney International · doi:10.1038/ki.2008.21 · Cited by 77
Self-citationAntigen presentation by renal tubular epithelial cells.
Rubin-Kelley, V. E., & Jevnikar, A. M. (1991) · Journal of the American Society of Nephrology · doi:10.1681/asn.v2113 · Cited by 75
Regulation of glomerular cell number by apoptosis
Savill, J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00707.x · Cited by 65
Renal cortical cholesterol accumulation is an integral component of the systemic stress response
Zager, R. A., & Johnson, A. C. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00071.x · Cited by 58
Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases.
Egido, J., Marta Gómez-chiarri, G., Ortíz, A., Bustos, C., Alonso, J., Gómez‐Guerrero, C., Gómez‐Garré, D., López-Armada, M. J., Plaza, J. J. G., & Gonzalez, E. (1993) · PubMed · Cited by 52
Oh, Y. J., An, J. N., Kim, C. T., Yang, S. H., Lee, H., Kim, D. K., Joo, K. W., Paik, J. H., Kang, S., Park, J. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132826 · Cited by 29
The human platelet fibrinogen receptor: clinical and therapeutic significance.
Cahill, M., Mistry, R., & Barnett, D. B. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb03993.x · Cited by 28
Carlsson, A. C., Nordquist, L., Larsson, T. E., Carrero, J. J., Larsson, A. O., Lind, L., & Ärnlöv, J. (2015) · Cardiorenal Medicine · doi:10.1159/000435863 · Cited by 25
Park, S., Chang, Y. H., Cho, Y. J., Ahn, H., Yang, W. S., Park, J. S., & Lee, J. D. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)00666-6 · Cited by 11
Self-citation
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Ridker, P. M., Devalaraja, M., Baeres, F. M. M., Engelmann, M. D. M., Hovingh, G. K., Ivkovic, M., Lo, L., Kling, D., Pergola, P., Raj, D., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00520-1 · Cited by 737
Self-citationInterleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
“In a recent study that analyses the association between a set of inflammatory biomarkers and progression of CKD in the Chronic Renal Insufficiency Cohort, the authors reported that elevated circulating levels of fibrinogen and TNF-α and decreased serum albumin are linked with the rapid loss of kidney function in patie…”
BackgroundAKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
He, L., Wei, Q., Liu, J., Yi, M., Liu, Y., Liu, H., Sun, L., Peng, Y., Liu, F., Venkatachalam, M. A., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.06.030 · Cited by 448
Metadata
- Authors
- Amdur, R. L., Feldman, H. I., Gupta, J., Yang, W., Kanetsky, P., Shlipak, M., Rahman, M., Lash, J. P., Townsend, R. R., Ojo, A., Roy-Chaudhury, A., Go, A. S., Joffe, M., He, J., Balakrishnan, V. S., Kimmel, P. L., Kusek, J. W., Raj, D. S., & the CRIC Study Investigators
- Affiliations
- George Washington University (US)
- Corresponding author
- Raj, Dominic S.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-06-23
- Volume
- 11
- Issue
- 9
- Pages
- 1546-1556
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5012490
- OpenAlex
- W2462073489
- Cited by
- 452
- References
- 46
- Citations by year
- 2026: 33 · 2025: 62 · 2024: 48 · 2023: 61 · 2022: 59 · 2021: 57 · 2020: 49 · 2019: 31 · 2018: 23 · 2017: 25 · 2016: 3
- FWCI
- 27.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000433, UL1TR000424, UL1TR000003, UL1TR000439, UL1TR001878)
- National Institute of General Medical Sciences (P30GM103337)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072231, U01DK060990, U01DK099924, U01DK099914, R01DK073665, R01DK139225, U01DK060984, U01DK060902, U01DK060980, U01DK061022, U01DK060963, U01DK061021, U01DK061028)
- National Center for Research Resources (UL1RR024131, M01RR016500, UL1RR029879)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease progression, inflammation, fibrinogen, interleukin-6, TNF-α, serum albumin, C-reactive protein, end-stage renal disease, estimated glomerular filtration rate decline, albuminuria, CRIC study, biomarkers of inflammation
- MeSH terms
- Adult, Aged, C-Reactive Protein, Female, Fibrinogen, Follow-Up Studies, Glomerular Filtration Rate, Humans, Inflammation, Interleukin-1, Kidney Failure, Chronic, Male, Middle Aged, Serum Albumin, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Transforming Growth Factor beta, Disease Progression, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.